Philippe Pichat

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Philippe Pichat, Olivier Bergis, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2006 · 237 citations

Medicine, Neuroscience, Pharmacology +13

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova et al. · Neuropsychopharmacology · 2007 · 117 citations

Medicine, Pharmacology, Psychiatry +14

Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

Guy Griebel, Philippe Pichat, Sandra Beeské et al. · Scientific Reports · 2015 · 110 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents

Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha et al. · Scientific Reports · 2019 · 95 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆

Denis Boulay, Philippe Pichat, Gihad Dargazanli et al. · Pharmacology Biochemistry and Behavior · 2008 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +8